Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 73, Issue 4, 2005, Pages 229-238

  Okada, Akinobu ^a   Kushima, Kiyoshi ^a   Aoki, Yoshinobu ^a   Bialer, Meir ^b   Fujiwara, Michio ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Microarray; Neural tube closure; Neural tube defects; Valnoctamide; Valproic acid; Valpromide

Indexed keywords

VALNOCTAMIDE; VALPROIC ACID; VALPROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCNE2 GENE; CCNL GENE; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; EARLY RESPONSE GENE; EGR2 GENE; EMBRYO; FEMALE; GADD45B GENE; GAS5 GENE; GENE; GENE EXPRESSION; GENE ISOLATION; GESTATIONAL AGE; IER5 GENE; MALE; MOUSE; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PER1 GENE; PHFL3 GENE; POU3F1 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIRT1 GENE; SOX4 GENE; TERATOGENESIS; ZFP105 GENE;

ABNORMALITIES, DRUG-INDUCED; AMIDES; ANIMALS; EMBRYO; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MICE; NEURAL TUBE DEFECTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; VALPROIC ACID;

EID: 18144374152     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20131     Document Type: Article

References (61)

1. Ahn JI, Lee KH, Shin DM, et al. 2004. Comprehensive transcriptome analysis of differentiation of embryonic stem cells into midbrain and hindbrain neurons. Dev Biol 265:491-501.
2. Bennett GD, Wlodarczyk B, Calvin JA, et al. 2000. Valproic acid-induced alterations in growth and neurotrophic factor. Reprod Toxicol 14:1-11.
3. Bialer M. 1999. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs. J Control Release 62:187-192.
4. Chang YL, Peng YH, Pan IC, et al. 2001. Essential role of Drosophila Hdac1 in homeotic gene silencing. Proc Natl Acad Sci USA 98:9730-9735.
5. Chen EY, Fujinaga M, Giaccia AJ. 1999. Hypoxic microenvironment within an embryo induced apoptosis and is essential for proper morphological development. Teratology 60:215-225.
6. Cheng HL, Mostoslavsky R, Saito S, et al. 2003. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100:10794-10799.
7. Cheung M, Abu-Elmagd M, Clevers H, Scotting PJ. 2000. Roles of Sox4 in central nervous system development. Mol Brain Res 79:180-191.
8. Coccia EM, Cicala C, Charlesworth A, et al V. 1992. Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. Mol Cell Biol 12:3514-3521.
9. Copp AJ, Brook FA, Roberts HJ. 1988. A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryo developing spinal neural tube defects. Development 104:285-295.
10. Craig JC, Bennett GD, Miranda RC, et al. 2000. Ribonucleotide reductase subunit r1: a gene conferring sensitivity to valproic acid-induced neural tube defects in mice. Teratology 61:305-313.
11. Dansky LV, Finnell RH. 1991. Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: human studies. Reprod Toxicol 5:301-335.
12. Del Sal G, Ruaro ME, Philipson L, Schneider C. 1992. The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 70:595-607.
13. Docterman KE, Smith SM. 2002. Of meis and men: lessons from a microarray study of teratogen action. Teratology 66:217-223.
14. Ehlers K, Stürje H, Merker H, Nau H. 1992. Valproic aid-induced spina bifida: a mouse model. Teratology 45:145-154.
15. Finnell RH, Dansky LV. 1991. Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: animal studies. Reprod Toxicol 5:281-299.
16. Finnell RH, Junker WM, Wadman LK, Cabrera RM. 2002. Gene expression profiling within the developing neural tube. Neurochem Res 27:1165-1180.
17. Finnell RH, Gould A, Spiegelstein O. 2003. Pathobiology and genetics of neural tube defects. Epilepsia 44(Suppl 3):14-23.
18. Gasser SM, Cockell MM. 2001. The molecular biology of the SIR proteins. Gene 279:1-16.
19. Geng Y, Yu Q, Whoriskey W, et al. 2001. Expression of cyclins E1 and E2 during mouse development and in neoplasia. Proc Natl Acad Sci USA 98:13138-13143.
20. Ghazvini M, Mandemakers W, Jaegle M, et al. 2002. A cell type-specific allele of the POU gene Oct-6 reveals Schwarun cell autonomous function in nerve development and regeneration. EMBO J 21:4612-4620.
21. Golden JA, Chernoff GF. 1993. Intermittent pattern of neural tube closure in two strains of mice. Teratology 47:73-80.
22. Göttlicher M, Minucci S, Zhu P, et al. 2001. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20:6969-6978.
23. Guarente L. 2000. Sir2 links chroma tin silencing, metabolism, and aging. Genes Dev 14:1021-1026.
24. Gumz ML, Popp MP, Wingo CS, Cain BD. 2003. Early transcriptional effects of aldosterone in a mouse inner medullary collecting duct cell line. Am J Physiol Renal Physiol 285:F664-F673.
25. Harris MJ, Juriloff DM. 1999. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice. Teratology 60:292-305.
26. Imai S, Armstrong CM, Kaeberlein M, Guarente L. 2000. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800.
27. Isoherranen N. 2003. Pharmacokinetic-pharmacodynamic relationships of 2S,3S-valnocatmide and its stereoisomer 2R,3S-valnoctamide in animal model for epilepsy. Pharm Res 20:1293-1301.
28. Jackman J, Alamo Jr I, Fornace Jr AJ. 1994. Genotoxic stress confers preferential and coordinate messenger RNA stability on the five GADD genes. Cancer Res 54:5656-5662.
29. Jeong MR, Hashimoto R, Senatorov VV, et al. 2003. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEES Lett 542:74-78.
30. Jin K, Mao XO, Eshoo MW, et al. 2002. cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro. Neurochem Res 27:1105-1112.
31. Kao J, Brown NA, Schmid B, et al. 1981. Teratogenicity of valproic acid: in vivo and in vitro investigations. Teratogenesis Carcinog Mutagen 1:367-382.
32. Keen CL, Taubeneck MW, Daston GP, et al. 1993. Primary and secondary zinc deficiency as factors underlying abnormal CNS development. Ann NY Acad Sci 678:37-47.
33. Kultima K, Nyström AM, Scholz B, et al. 2004. Valproic acid teratogenicity: a toxicogenomics approach. Environ Health Perspect 112:1225-1235.
34. Lauper N, Beck ARP, Cariou S, et al. 1998. Cyclin E2: a novel CDK2 partner in the G1 and S phases of the mammalian cell cycle. Oncogene 17:2637-2643.
35. Martin ML, Regan CM. 1991. The anticonvulsant valproate teratogen restricts the glial cell cycle at a defined point in the mid-G1 phase. Brain Res 554:223-228.
36. McBurney MW, Yang X, Jardine K, et al. 2003. The mammalian SIR2α protein has a role in embryogenesis and gametogenesis. Mol Cell Biol 23:38-54.
37. Menegola E, Broccia ML, Nau H, et al. 1996. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratog Carcinog Mutagen 16:97-108.
38. Moore M, Keane PE, Vernieres JC, et al. 1984. Valproate: recent findings and perspectives. Epilepsia 25(Suppl 1):S5-S9.
39. Okada A, Kurihara H, Aoki Y, et al. 2004a. Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Birth Defects Res Part B Dev Reprod Toxicol 71:47-53.
40. Okada A, Aoki Y, Kushima K, et al. 2004b. Polycomb homologues are involved in teratogenicity of valproic acid in mice. Birth Defects Res Part A Clin Mol Teratol 70:870-879.
41. Phiel CJ, Zhang F, Huang EY, et al. 2001. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734-36741.
42. Przyborski SA, Knowles BB, Handel MA, et al. 1998. Differential expression of the zinc finger gene Zfp105 during spermatogenesis. Mamm Genome 9:758-762.
43. Radatz M, Ehlers K, Yagen B, et al. 1998. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res 30:41-48.
44. Record IR, Tulsi RS, Dreosti IE, Fraser FJ. 1985. Cellular necrosis in zinc-deficient rat embryos. Teratology 32:397-405.
45. Ryan AK, Rosenfeld MG. 1997. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 11:1207-1225.
46. Sah VP, Attardi LD, Mulligan GJ, et al. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 10:175-179.
47. Sakamoto J, Miura T, Shimamoto K, Horio Y. 2004. Predominant expression of Sir2α, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain. FEBS Lett 556:281-286.
48. Schneider C, King RM, Philipson L. 1988. Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787-793.
49. Schneider-Maunoury S, Seitarddou T, Charnay P, Lumsden A. 1997. Segmental and neuronal architecture of the hindbrain of Krox-20 mouse mutants. Development 124:1215-1226.
50. Sgambato V, Minassian R, Nairn AC, Hyman SE. 2003. Regulation of ania-6 splice variants by distinct signaling pathway in striatal neurons. J Neurochem 86:153-164.
51. Smith ML, Chen IT, Zhan Q, et al. 1994. Interaction of the p53-regulated protein GADD45 with proliferating nuclear cell antigen. Science 266:1376-1379.
52. Stokes AH, Freeman WM, Mitchell SG, et al. 2002. Induction of GADD45 and GADD153 in neuroblastoma cells by dopamine-induced toxicity. Neurotoxicology 23:675-684.
53. Sun ZS, Albrecht U, Zhuchenko O, et al. 1997. RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell 90:1003-1011.
54. Swiatek PJ, Gridley T. 1993. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev 7:2071-2084.
55. Vacha SJ, Bennett GD, Mackler SA, et al. 1997. Identification of a growth arrest specific (gas5) gene by differential display as a candidate gene for determining susceptibility to hyperthermia-induced exencephaly in mice. Dev Genet 21:212-222.
56. Warkany J, Petering HG. 1972. Congenital malformations of the central nervous system in rats produced by maternal zinc deficiency. Teratology 5:319-334.
57. Williams M, Lyu MS, Yang YL, et al. 1999. Ier5, a novel member of the slow-kinetics immediate-early genes. Genomics 55:327-334.
58. Wilson DB. 1974. Proliferation in the neural tube of the splotch (Sp) mutant mouse. J Comp Neurol 154:249-256.
59. Wilson DB, Center EM. 1974. Neural cell cycle in the Looptail mutant of the mouse (Lp). J Embryol Exp Morphol 32:697-705.
60. Wlodarczyk BJ, Bennett GD, Calvin JA, Finnell RH. 1996. Arsenic-induced neural tube defects in mice: alterations in cell cycle and gene expression. Reprod Toxicol 10:447-454.
61. Zhan Q, Bae I, Kastan MB, Fornace AJ Jr. 1994. The p53-dependent gamma-ray response of GADD45. Cancer Res 54:2755-2760.